LEADER 04567nam 22006975 450 001 9910300226203321 005 20200702113327.0 010 $a4-431-54977-3 024 7 $a10.1007/978-4-431-54977-2 035 $a(CKB)3710000000268466 035 $a(EBL)1966200 035 $a(OCoLC)908085267 035 $a(SSID)ssj0001372611 035 $a(PQKBManifestationID)11782330 035 $a(PQKBTitleCode)TC0001372611 035 $a(PQKBWorkID)11305236 035 $a(PQKB)11120041 035 $a(DE-He213)978-4-431-54977-2 035 $a(MiAaPQ)EBC1966200 035 $a(PPN)182092364 035 $a(EXLCZ)993710000000268466 100 $a20141022d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEsophageal Squamous Cell Carcinoma $eDiagnosis and Treatment /$fedited by Nobutoshi Ando 205 $a1st ed. 2015. 210 1$aTokyo :$cSpringer Japan :$cImprint: Springer,$d2015. 215 $a1 online resource (313 p.) 300 $aDescription based upon print version of record. 311 $a4-431-54976-5 320 $aIncludes bibliographical references and index. 327 $a1. Epidemiology of ESCC -- 2. Pathology of Esophageal Squamous Cell Carcinoma -- 3. Imaging Diagnosis -- 4. Endoscopic Diagnosis of Squamous Cell Carcinoma of the Esophagus -- 5. Stage Classifications: The UICC/AJCC Classifications and The Japanese Classification -- 6. Comprehensive Registry in Japan -- 7. Guidelines for Diagnosis and Treatment in Japan -- 8. Surgery: Transthoracic Esophagectomy -- 9. Surgery: Minimally Invasive Esophagectomy -- 10. Surgery: Esophageal reconstruction -- 11. Neoadjuvant and Adjuvant Therapy -- 12. Chemotherapy and Chemoradiotherapy 13. Radiation Therapy -- 14. Endoscopic treatment: EMR and ESD -- 15. The Hong Kong Experience -- 16. The Indian Experience. 330 $aEsophageal cancer causes an estimated 386,000 deaths worldwide and is the sixth most common cause of death for men. The background characteristics of esophageal cancer treatment are markedly different between Asian and Western countries, however. In tumor histology, squamous cell carcinoma associated with smoking and alcohol consumption is overwhelmingly prevalent in Asia, whereas adenocarcinoma associated with Barrett?s metaplasia is markedly prevalent in the West. In Asia, especially in Japan, the key persons who play important roles in the management of esophageal cancer patients are surgeons; in the West those roles are filled by medical and radiation oncologists as well as surgeons. The philosophy of surgeons regarding cancer surgery varies from locoregional to local tumor control, particularly in focusing on lymph node dissection. Physicians? approach to surgical adjuvant therapy differs, therefore, between Asia and the West. Considering these East?West differences in esophageal cancer treatment, the currently available results of Western evidence should not be considered directly applicable to esophageal cancer in Asia. In this book, the authors discuss the knowledge base in Japan in terms of treatment of esophageal squamous cell carcinoma. Since this volume contains a wide spectrum of current information and addresses topics surrounding the treatment of patients with esophageal squamous cell carcinoma, it is highly relevant to Asian physicians and researchers as well as to their counterparts in the West. 606 $aOncology   606 $aSurgical oncology 606 $aGastroenterology  606 $aThoracic surgery 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aSurgical Oncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H59150 606 $aGastroenterology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33061 606 $aThoracic Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59095 615 0$aOncology  . 615 0$aSurgical oncology. 615 0$aGastroenterology . 615 0$aThoracic surgery. 615 14$aOncology. 615 24$aSurgical Oncology. 615 24$aGastroenterology. 615 24$aThoracic Surgery. 676 $a610 676 $a616.33 676 $a616994 676 $a617.54059 702 $aAndo$b Nobutoshi$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300226203321 996 $aEsophageal Squamous Cell Carcinoma$91762223 997 $aUNINA